This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Biochemical Assays Remove DNA Remove Webinar
article thumbnail

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

SEPTEMBER 29, 2022

During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”. Three common questions regarding the challenges when considering outsourcing partners for drug discovery. Conclusion.

Small Molecule 130
Small Molecule Assay Development DNA Biochemical Assays 130
article thumbnail

Article FDA Thank You Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

APRIL 12, 2024

Assays are tests designed to assess various properties (like potency) of chemical or biological samples. In an effort to further explain its current views on potency assurance, the FDA also recorded a webinar to accompany the new draft. Additionally, six of these comments came from the same organization (Integrated DNA Technologies).

Production 40
Production FDA Therapies Biochemical Assays 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024